WHO Approves Johnson & Johnson COVID-19 Vaccine For Emergency Use

Hamilton Nwosa
Writer
905m COVID-19 Shots Administered Worldwide – Report

Ad

Gasoline Prices Drop Toward Pandemic-Era Lows

The national average price of gasoline dropped below $3 a gallon over the weekend. GasBuddy has predicted that prices will go even lower in the coming weeks, with good prospects of motorists enjoying sub-$3 prices for extended periods. This drop is overwhelmingly being driven by the significant increase in oil production from OPEC throughout 2025.…

We’ve Paid Over N58b Bridging Claims To Oil Marketers – NMDPRA

Alleged Christian Genocide Claim is Damaging Nigeria’s Image– Tuggar Laments

By Abiola Olawale Minister of Foreign Affairs, Yusuf Tuggar, has voiced concern over what he described as the damaging impact of the "Christian genocide" narrative on Nigeria's international image. This is as the Minister claimed that the country's complex security challenges are being falsely simplified as religious persecution. Speaking at the Reuters NEXT Gulf Summit…

(Full List) Salah, Osimhen Nominated as CAF Unveils Nominees for 2025 African Male Player of the Year

By Abiola Olawale The Confederation of African Football (CAF) has officially released the much-anticipated shortlist for the 2025 African Men's Player of the Year award. Headlining the prestigious 10-man list are two of the continent's most electrifying stars: Egypt's Mohamed Salah (Liverpool) and Nigeria's Victor Osimhen (Galatasaray, on loan from Napoli). ​The release of the…

Ad

The World Health Organization (WHO) on Friday approved Johnson & Johnson’s Covid-19 vaccine, after already authorising the jabs made by Pfizer-BioNTech and Oxford-AstraZeneca.

“Every new, safe and effective tool against Covid-19 is another step closer to controlling the pandemic,” WHO chief Tedros Adhanom Ghebreyesus said in a statement.

The news comes after the single-dose jab won approval from the European Union on Thursday.

It has also received the green light from regulators in the United States, Canada and South Africa.

The World Health Organization said the Johnson & Johnson’s Covid-19 vaccine had been granted an “emergency use listing” which assesses the suitability of new health products during public health emergencies, and is quicker than the regular licensing system.

WHO authorisation paves the way for the jabs to be used as part of the Covax initiative aimed at ensuring equitable access to vaccines in poorer countries.

Some 500 million doses of the J&J jabs have been promised to the facility and the WHO hopes it can be rolled out through the scheme from July, if not earlier.

“We hope this new vaccine will help to narrow vaccine inequalities, and not deepen them,” Tedros told a briefing.

Clinical trials have found that the J&J shot was 67 percent effective at preventing people from getting Covid-19.

But that result considered all forms of Covid-19. The jab proved 85.4 percent effective at preventing severe disease.

And since this is a single-dose jab, WHO said it expected it to facilitate vaccination logistics in all countries.

“The sample data from large clinical trials shared by the company also shows that the vaccine is effective in older populations,” it said.

AFP

Ad

X whatsapp